Ipilimumab +/- Vaccine Therapy in Treating Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer

NCT00836407 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Ipilimumab
BIOLOGICAL: Pancreatic Cancer Vaccine

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins